Philadelphia, May 15, 2025 – XCMR’s Dr. Ben Robertson presented at the 44th Annual Surgical Infection Society (SIS) Meeting which took place on May 13–14, 2025, at the Loews Hotel in Philadelphia, PA.

About the Surgical Infection Society (SIS)

The SIS is a professional organization dedicated to the study, prevention, and management of infections in surgical patients. Established to advance the science of surgical infections, the society promotes research, education, and collaboration among healthcare professionals to improve patient outcomes. SIS serves as a forum for the exchange of knowledge and best practices, advocating for evidence-based approaches to infection control and the development of new treatments and technologies in the field of surgery. Through its activities, the society aims to reduce the incidence and impact of surgical infections globally.

SIS 2025 Annual Meeting covered:

  •         Cutting-Edge Research: Engagement with groundbreaking studies and innovative approaches to infection prevention and treatment.
  •         Expert Speakers: Presentations by renowned leaders in the field of surgical infections.
  •         Networking Opportunities: Ability to connect with peers and professionals dedicated to advancing patient care.

“XCMR was honored to participate in the Surgical Infection Society’s recent meeting on our home turf in Philadelphia. We had the opportunity to engage with surgeons across a variety of disciplines and deepen our understanding of the challenges they face related to preventing post-operative infections and wound care. By interfacing with world-leading experts in their respective surgical fields, we were able to gain valuable insight into how UV-C devices might be integrated into existing pre-, intra-, and post- operative workflows. These insights will be critical for building surgical site infection prevention devices that are not only safe and effective but also integrate seamlessly into patient care workflows to enhance their overall quality.”

 – Dr. Ben Robertson – Senior Director, Test Method Development and Analytics

About XCMR

XCMR leads in biosecurity innovation incorporating UV-C into wearable, portable, and stationary devices to prevent transmission of infectious diseases. XCMR’s IoT cloud enables  AI-driven predictive analytics to improve visibility, response, and preparedness for scaled infection transmission resiliency.

Breakthrough achievement. Based on science and research. Powered by a passion to improve health security for all.

Let's Partner.